Atlas Trials

Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

Clinical trial NCT03821701 · UNKNOWN

Trial details

NCT number
NCT03821701
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Heart Failure
Start date
2018-06-01
Primary completion
2021-01-31
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.